Synergistic effects of anti-CmeA and anti-CmeB peptide nucleic acids on sensitizing Campylobacter jejuni to antibiotics

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 9, 2013, Pages 4575-4577

  Mu, Yang ^a,b   Shen, Zhangqi ^b   Jeon, Byeonghwa ^c   Dai, Lei ^b   Zhang, Qijing ^b  

^a NORTHWEST A F UNIVERSITY   (China)

^b IOWA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CIPROFLOXACIN; ERYTHROMYCIN C; PEPTIDE NUCLEIC ACID; PROTEIN CMEA; PROTEIN CMEB; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CAMPYLOBACTER JEJUNI; CONTROLLED STUDY; GENE SEQUENCE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; WILD TYPE;

ANTI-BACTERIAL AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; BACTERIAL PROTEINS; CAMPYLOBACTER JEJUNI; CIPROFLOXACIN; CULTURE MEDIA; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG SYNERGISM; ERYTHROMYCIN; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; PEPTIDE NUCLEIC ACIDS;

EID: 84882439292     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00605-13     Document Type: Article

References (14)

1. Ruiz-Palacios GM. 2007. The health burden of Campylobacter infection and the impact of antimicrobial resistance: playing chicken. Clin. Infect. Dis. 44:701-703.
2. Luangtongkum T, Jeon B, Han J, Plummer P, Logue CM, Zhang Q. 2009. Antibiotic resistance in Campylobacter: emergence, transmission and persistence. Future Microbiol. 4:189-200.
3. Lin J, Michel LO, Zhang Q. 2002. CmeABC functions as a multidrug efflux system in Campylobacter jejuni. Antimicrob. Agents Chemother. 46:2124-2131.
4. Lin J, Sahin O, Michel LO, Zhang Q. 2003. Critical role of multidrug efflux pump CmeABC in bile resistance and in vivo colonization of Campylobacter jejuni. Infect. Immun. 71:4250-4259.
5. Quinn T, Bolla JM, Pages JM, Fanning S. 2007. Antibiotic-resistant Campylobacter: could efflux pump inhibitors control infection? J. Antimicrob. Chemother. 59:1230-1236.
6. Hannula M, Hanninen ML. 2008. Effect of putative efflux pump inhibitors and inducers on the antimicrobial susceptibility of Campylobacter jejuni and Campylobacter coli. J. Med. Microbiol. 57:851-855.
7. Mamelli L, Amoros JP, Pages JM, Bolla JM. 2003. A phenylalaninearginine beta-naphthylamide sensitive multidrug efflux pump involved in intrinsic and acquired resistance of Campylobacter to macrolides. Int. J. Antimicrob. Agents 22:237-241.
8. Corradini R, Sforza S, Tedeschi T, Totsingan F, Manicardi A, Marchelli R. 2011. Peptide nucleic acids with a structurally biased backbone. Updated review and emerging challenges. Curr. Top. Med. Chem. 11:1535-1554.
9. Paulasova P, Pellestor F. 2004. The peptide nucleic acids (PNAs): a new generation of probes for genetic and cytogenetic analyses. Ann. Genet. 47:349-358.
10. Jeon B, Zhang Q. 2009. Sensitization of Campylobacter jejuni to fluoroquinolone and macrolide antibiotics by antisense inhibition of the Cme-ABC multidrug efflux transporter. J. Antimicrob. Chemother. 63:946-948.
11. Kilk K, Langel U. 2005. Cellular delivery of peptide nucleic acid by cellpenetrating peptides. Methods Mol. Biol. 298:131-141.
12. Luo N, Pereira S, Sahin O, Lin J, Huang S, Michel L, Zhang Q. 2005. Enhanced in vivo fitness of fluoroquinolone-resistant Campylobacter jejuni in the absence of antibiotic selection pressure. Proc. Natl. Acad. Sci. U. S. A. 102:541-546.
13. Luangtongkum T, Shen Z, Seng VW, Sahin O, Jeon B, Liu P, Zhang Q. 2012. Impaired fitness and transmission of macrolide-resistant Campylobacter jejuni in its natural host. Antimicrob. Agents Chemother. 56:1300-1308.
14. Hatamoto M, Ohashi A, Imachi H. 2010. Peptide nucleic acids (PNAs) antisense effect to bacterial growth and their application potentiality in biotechnology. Appl. Microbiol. Biotechnol. 86:397-402.